| 摘要 |
<p>Process for the preparation of a pharmaceutic composition having a selective immunity adjuvant action bringing into play a humoral response or a cellular mediation response, preferably both at once, directed against given antigens, in the absence of any induction of auto-immune disease linked to a response to auto-antigenic determinants. The adjuvant principle of said pharmaceutic composition consists of MDP-DD-GDP of formula (I).</p> |
